FGF21 transcription is induced by peroxisome proliferator-activated receptor (PPAR)-γ and PPAR-α, which are the targets of agents prescribed to treat T2DM (thiazolidinediones) and hyperlipidemia (fibrates), respectively (23, 30). The gene discussed is FGF21; the disease is type 2 diabetes mellitus.